...
首页> 外文期刊>Cancer biotherapy and radiopharmaceuticals >Influence of Glutathione Depletion on Plasma Membrane Cholesterol Esterification and on Tc-99m-Sestamibi and Tc-99m-Tetrofosmin Uptakes: A Comparative Study in Sensitive U-87-MG and Multidrug-Resistant MRP1 Human Glioma Cells.
【24h】

Influence of Glutathione Depletion on Plasma Membrane Cholesterol Esterification and on Tc-99m-Sestamibi and Tc-99m-Tetrofosmin Uptakes: A Comparative Study in Sensitive U-87-MG and Multidrug-Resistant MRP1 Human Glioma Cells.

机译:谷胱甘肽耗竭对血浆膜胆固醇酯化和Tc-99m-Sestamibi和Tc-99m-Tetrofosmin摄取的影响:敏感性U-87-MG和耐多药MRP1人胶质瘤细胞的比较研究。

获取原文
获取原文并翻译 | 示例

摘要

In our previous studies, we demonstrated a possible effect of cellular glutathione (GSH) depletion on plasma-membrane permeability and fluidity in glioma-cell lines. We therefore investigated the effect of GSH modulation on accumulation of two radiotracers, Tc-99m-sestamibi (MIBI) and Tc-99m-tetrofosmin (TFOS), and on plasma-membrane cholesterol content in sensitive U-87-MG and resistant U-87-MG-CIS and U-87-MG-MEL (MRP1 positive) human glioma-cell lines. GSH depletion was mediated by BSO pretreatment and addition of N-acetylcysteine reversed the effect. MIBI and TFOS uptakes, total cholesterol, and cholesteryl-ester contents were evaluated under each condition. In contrast with TFOS, MIBI accumulation was inversely proportional to the cell multidrug resistance phenotype. Similar cholesterol contents were observed in all cell lines, demonstrating that MRP1 did not modify lipid membrane composition. A decrease of intracellular GSH allows an increase of plasma-membrane cholesterol and a decrease of cholesteryl-ester content, which in turn results in spectacular TFOS uptake. The GSH status of the cells plays an important role in the plasma membrane cholesterol composition and TFOS uptake, which appears to be particularly sensitive to this modification. In contrast with MIBI, TFOS is not an MRP1 probe in glioma cells, and therefore appears to be a suitable tracer in this indication.
机译:在我们以前的研究中,我们证明了胶质瘤细胞系中细胞谷胱甘肽(GSH)耗竭对血浆膜通透性和流动性的可能影响。因此,我们研究了GSH调制对两种放射性示踪剂Tc-99m-sestamibi(MIBI)和Tc-99m-tetrofosmin(TFOS)的累积以及敏感U-87-MG和耐药U-中血浆膜胆固醇含量的影响87-MG-CIS和U-87-MG-MEL(MRP1阳性)人神经胶质瘤细胞系。 GSH耗竭是通过BSO预处理介导的,添加N-乙酰半胱氨酸可以逆转这种作用。在每种条件下评估MIBI和TFOS的摄取,总胆固醇和胆固醇酯含量。与TFOS相反,MIBI积累与细胞多药耐药性表型成反比。在所有细胞系中观察到相似的胆固醇含量,表明MRP1不会改变脂质膜的组成。减少细胞内GSH可以增加血浆膜胆固醇和减少胆固醇酯含量,进而导致大量的TFOS吸收。细胞的GSH状态在质膜胆固醇组成和TFOS摄取中起着重要作用,这似乎对这种修饰特别敏感。与MIBI相反,TFOS不是神经胶质瘤细胞中的MRP1探针,因此在此适应症中似乎是合适的示踪剂。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号